3,650 Shares in National HealthCare Corporation $NHC Bought by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd acquired a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 3,650 shares of the company’s stock, valued at approximately $583,000.

A number of other hedge funds also recently added to or reduced their stakes in NHC. Royal Bank of Canada grew its position in shares of National HealthCare by 53.6% during the first quarter. Royal Bank of Canada now owns 2,724 shares of the company’s stock worth $253,000 after acquiring an additional 950 shares during the last quarter. AQR Capital Management LLC lifted its position in National HealthCare by 1.7% in the 1st quarter. AQR Capital Management LLC now owns 16,080 shares of the company’s stock valued at $1,492,000 after purchasing an additional 262 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in National HealthCare by 3.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,247 shares of the company’s stock valued at $858,000 after purchasing an additional 281 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in National HealthCare by 7.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 73,772 shares of the company’s stock valued at $6,846,000 after purchasing an additional 4,879 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in National HealthCare by 18.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 30,246 shares of the company’s stock valued at $2,807,000 after purchasing an additional 4,628 shares during the period. 56.44% of the stock is currently owned by institutional investors.

National HealthCare Stock Down 1.2%

NHC stock opened at $207.87 on Tuesday. The company has a 50-day simple moving average of $196.54 and a 200 day simple moving average of $170.16. The company has a market capitalization of $3.25 billion, a P/E ratio of 26.41 and a beta of 0.63. National HealthCare Corporation has a fifty-two week low of $93.54 and a fifty-two week high of $220.86.

National HealthCare (NYSEAMERICAN:NHC) last released its earnings results on Thursday, May 7th. The company reported $1.91 EPS for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%. The firm had revenue of $381.82 million for the quarter.

National HealthCare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.67 per share. This is a boost from National HealthCare’s previous quarterly dividend of $0.64. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Tuesday, June 30th. National HealthCare’s dividend payout ratio (DPR) is 61.89%.

Wall Street Analysts Forecast Growth

Several research firms have commented on NHC. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Robert W. Baird upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Royal Bank Of Canada raised National HealthCare to a “hold” rating in a report on Monday, May 18th. Finally, The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, National HealthCare has a consensus rating of “Buy”.

Insider Activity at National HealthCare

In other news, Director Lisa Piercey bought 949 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were purchased at an average price of $184.26 per share, with a total value of $174,862.74. Following the completion of the acquisition, the director directly owned 949 shares in the company, valued at approximately $174,862.74. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 13.92% of the stock is owned by corporate insiders.

National HealthCare Company Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.